Home › Smoking and Youth › NCT06442514
Pain and Smoking Study 2.0: A Randomized Clinical Trial of Smoking Cessation Among Veterans With Chronic Pain
Enhancing an Intervention for Smokers With Chronic Pain Using IVR: A Randomized Clinical Trial of Smoking Cessation Counseling for Veterans
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * being an enrolled Veteran at VACHS * current tobacco use * willingness to make a quit attempt * significant chronic pain defined as \>/=4 on the pain intensity portion of the Brief Pain Inventory (BPI) for more than 90 days Exclusion Criteria: * active diagnosis of dementia or psychosis in medical record * severely impaired hearing or speech * lack of telephone access * enrollment in concurrent research study that might affect main outcomes of this study * terminal illness * non-English speaking * pregnancy * provider advising against exercise * planned surgeries * clinically significant depressive symptoms (\>10 PHQ-9)
About the study
PASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cognitive behavioral intervention (CBI). This study will use nightly surveys to optimize the intervention's effectiveness for smoking cessation among Veteran smokers with chronic pain.
What is being tested
- PASS2 (behavioral)
- Treatment as Usual (other)
Sponsor: VA Office of Research and Development · Participants: 220 · Started: Sep 21, 2026
Contact the study team
- Lori A Bastian, MD MPH · Phone: (203) 932-5711
- Mary Driscoll, PhD · Phone: (203) 932-5744
Official record on ClinicalTrials.gov — NCT06442514
Locations in the U.S.
| Connecticut | VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.